Filing Details
- Accession Number:
- 0001179110-15-000943
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-15 19:43:40
- Reporting Period:
- 2015-01-13
- Filing Date:
- 2015-01-15
- Accepted Time:
- 2015-01-15 19:43:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550424 | Mark Rothera | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-01-13 | 3,000 | $56.51 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-13 | 5,500 | $10.85 | 11,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-13 | 5,500 | $58.75 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-14 | 1,200 | $10.85 | 7,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-14 | 1,200 | $58.62 | 6,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | Acquisiton | 2015-01-13 | 5,500 | $0.00 | 5,500 | $10.85 |
| Common Stock | Stock Option (Right To Buy) | Acquisiton | 2015-01-14 | 1,200 | $0.00 | 1,200 | $10.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 141,500 | 2023-05-15 | No | 4 | M | Direct | |
| 140,300 | 2023-05-15 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.30 to $56.81 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.60 to $59.00 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option was granted on May 15, 2013. 25% of the grant vested on May 15, 2014. The remainder vests as to 1/48 of the shares underlying such option each month until May 2017. One additional share was incorrectly reflected as exercised in the reporting person's Form 4 filed on September 26, 2014 and that error is corrected here.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.60 to $58.72 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
